Skip to main content
Fig. 3 | Arthritis Research & Therapy

Fig. 3

From: Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis

Fig. 3

Serum Cyr61 levels in RA patients in the validation cohort before and after treatment. a Left to right: scatter plots showing the levels of Cyr61 in ACR20 responders, ACR50 responders, ACR70 responders, and ACR non-responders before and after treatment. b Left to right: before-after plots showing the levels of Cyr61 in ACR20 responders, ACR50 responders, ACR70 responders, and ACR non-responders before and after treatment (in correspondence with a). The red horizontal solid line represents a median value

Back to article page